Advertisement Systech SSPs to address scalability concerns in pharmaceutical serialization market - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Systech SSPs to address scalability concerns in pharmaceutical serialization market

US-based pharmaceutical serialization solutions provider Systech International is planning to use its international network of Select Service Providers (SSPs) to address the issue of scalability in the serialization market.

The scalability solution has become a major concern with over 10,000 lines to be serialized within the life sciences industry over the next 5 years, according to the company.

Systech International Business Development VP Barry Mc Donogh said the company’s approach is a proven strategy used in other high-growth markets (SCADA, MES) where scalability has been an issue.

"By focusing on its competitive differentiators and leveraging the core competencies of its trusted partners, Systech can offer its customers an economic, effective and reliable means of delivering their serialization programs," Mc Donogh added.

Currently Systech has several SSPs, which provide the company with access to thousands of engineers and project managers globally.

The company is training, certifying and deploying these resources on its engagements and expecting to triple its in-house implementation capacity by the end of 2013.

Systech’s technologies offer improved support, local knowledge and the potential for substantial cost savings, apart from providing scalability.